組織工学および再生医療：各種技術と世界市場

世界の組織工学および再生医療の市場規模は、2024年の48億米ドル、2025年の54億米ドルから、2025年から2030年にかけてはCAGR 12.8%で推移し、2030年には98億米ドルに達すると予測されています。

北米市場は、2024年の21億米ドル、2025年の24億米ドルから、予測期間中はCAGR 13.3%で推移し、2030年には45億米ドルに達すると予測されています。アジア太平洋市場は、2024年の8億8,840万米ドル、2025年の10億米ドルから、CAGR 15.5%で推移し、2030年には21億米ドルに達すると予測されています。

当レポートでは、世界の組織工学および再生医療の市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析などをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場サマリー

第2章 市場概要

• 概要
• ポーターのファイブフォース分析
• マクロ経済要因分析
• 高齢化人口
• 規制環境
• 政府の政策と協力
• 米国の関税シナリオ

第3章 市場力学

• 市場力学
• 市場促進要因
• 再生医療の需要の高まり
• 組織工学における研究と承認の増加
• ベンチャーキャピタルからの資金調達の増加
• 市場抑制要因
• 治療にかかる高額な費用
• 複雑な制御経路
• 市場機会
• 技術の進歩
• 新興経済国

第4章 規制状況

• 米国
• 欧州
• アジア太平洋

第5章 組織工学および再生医療市場へのAI導入による影響

• 概要
• ケーススタディ
• 問題
• ソリューション
• 成果
• AI導入の動向
• 北米における導入動向
• 欧州における導入動向
• その他の地域における導入動向
• AIによる破壊的変化の動向
• バリューチェーンのさまざまな段階におけるAIの影響
• 市場支出と投資シナリオ
• AIへのVC投資

第6章 新興技術と開発

• 新興技術
• 3Dバイオプリンティング
• 臓器チップ
• スマートバイオマテリアル
• AI
• 臨床試験分析
• 重要ポイント
• 臨床試験分析：研究タイプ別
• 臨床試験分析：ステータス別
• 臨床試験分析：フェーズ別
• 特許分析
• 重要ポイント
• 特許：年別
• 特許：主要出願人別
• 特許：トップオーナー別
• 特許：管轄別

第7章 市場セグメンテーション分析

• セグメンテーションの内訳
• 市場分析：製品タイプ別
• 重要ポイント
• スキャフォールド
• 生物由来スキャフォールド
• 合成スキャフォールド
• 移植片
• 同種移植片
• 自家移植片
• 合成移植片
• 異種移植片
• 市場分析：材料別
• 重要ポイント
• 生物由来材料
• 合成材料
• 市場分析：用途別
• 重要ポイント
• 整形外科および筋骨格系疾患
• 皮膚科および創傷ケア
• 歯科疾患
• 心血管疾患
• その他
• 地理的内訳
• 市場分析：地域別
• 重要ポイント
• 北米
• 欧州
• アジア太平洋
• 中東・アフリカ
• 南米

第8章 競合情報

• 重要ポイント
• 競合情勢
• 主要企業の世界市場シェア
• 主な発展と戦略

第9章 組織工学および再生医療における持続可能性：ESGの観点

• ESG：イントロダクション
• 組織工学および再生医療における持続可能性：ESGの観点
• 主要なESG上の課題
• 組織工学および再生医療：ESGパフォーマンス分析
• BCCからの結論

第10章 付録

• 調査手法
• 出典
• 略語
• 企業プロファイル
• ABBVIE INC.
• ALICORN MEDICAL PVT. LTD.
• BAXTER
• B. BRAUN SE
• BD
• BIOTISSUE
• INTEGRA LIFESCIENCES
• JOHNSON & JOHNSON SERVICES INC.
• MEDTRONIC
• MIMEDX GROUP INC.
• ORGANOGENESIS INC.
• SMITH+NEPHEW
• STRYKER
• TECNOSS
• ZIMMER BIOMET
• 新興スタートアップ企業/市場破壊者

List of Tables

• Summary Table : Global Market for Tissue Engineering and Regeneration, by Region, Through 2030
• Table 1 : Porter's Five Forces Analysis: Overview
• Table 2 : Tissue Engineering and Regeneration: Venture Capital Funding, 2024
• Table 3 : Tissue Engineering & Regeneration: Pricing
• Table 4 : Tissue Engineering and Regeneration: Regulatory Overview, 2025
• Table 5 : Asia-Pacific: Regulatory Landscape, 2024
• Table 6 : Clinical Trials in Tissue Engineering, by Type of Study, June 2025
• Table 7 : Clinical Trials in Tissue Engineering, by Status, June 2025
• Table 8 : Clinical Trials in Tissue Engineering, by Phase, June 2025
• Table 9 : Patents, by Top Applicant, 2021-2024
• Table 10 : Patents, by Top Owner, 2021-2024
• Table 11 : Patents, by Jurisdiction, 2021-2024
• Table 12 : Global Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
• Table 13 : Comparison of Extracellular Matrix Functions and Scaffold Analogs in Tissue Engineering
• Table 14 : Global Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
• Table 15 : Biological Scaffold Materials: Advantages and Disadvantages
• Table 16 : Synthetic Scaffold Materials: Advantages and Disadvantages
• Table 17 : Global Market for Grafts in Tissue Engineering and Regeneration, by Source, Through 2030
• Table 18 : List of Bioengineered Autogenic Grafts
• Table 19 : Global Market for Tissue Engineering and Regeneration, by Material, Through 2030
• Table 20 : Tissue Engineering and Regeneration: Biomaterial
• Table 21 : Global Market for Tissue Engineering and Regeneration, by Application, Through 2030
• Table 22 : Orthopedics and Musculoskeletal Disorders: Tissue Engineering and Regeneration Product
• Table 23 : Dermatology and Wound Care: Tissue Engineering and Regeneration Products
• Table 24 : Global Market for Tissue Engineering and Regeneration, by Region, Through 2030
• Table 25 : North American Market for Tissue Engineering and Regeneration, by Country, Through 2030
• Table 26 : North American Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
• Table 27 : North American Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
• Table 28 : North American Market for Grafts in Tissue Engineering and Regeneration, by Source, Through 2030
• Table 29 : North American Market for Tissue Engineering and Regeneration, by Material, Through 2030
• Table 30 : North American Market for Tissue Engineering and Regeneration, by Application, Through 2030
• Table 31 : European Market for Tissue Engineering and Regeneration, by Country, Through 2030
• Table 32 : European Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
• Table 33 : European Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
• Table 34 : European Market for Grafts in Tissue Engineering and Regeneration, by Source, Through 2030
• Table 35 : European Market for Tissue Engineering and Regeneration, by Material, Through 2030
• Table 36 : European Market for Tissue Engineering and Regeneration, by Application, Through 2030
• Table 37 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Country, Through 2030
• Table 38 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
• Table 39 : Asia-Pacific Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
• Table 40 : Asia-Pacific Market for Graft in Tissue Engineering and Regeneration, by Source, Through 2030
• Table 41 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Material, Through 2030
• Table 42 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Application, Through 2030
• Table 43 : MEA Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
• Table 44 : MEA Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
• Table 45 : MEA Market for Graft in Tissue Engineering and Regeneration, by Source, Through 2030
• Table 46 : MEA Market for Tissue Engineering and Regeneration, by Material, Through 2030
• Table 47 : MEA Market for Tissue Engineering and Regeneration, by Application, Through 2030
• Table 48 : South American Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
• Table 49 : South American Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
• Table 50 : South American Market for Graft in Tissue Engineering and Regeneration, by Source, Through 2030
• Table 51 : South American Market for Tissue Engineering and Regeneration, by Material, Through 2030
• Table 52 : South American Market for Tissue Engineering and Regeneration, by Application, Through 2030
• Table 53 : Top 5 Leading Manufacturers of Tissue Engineering and Regeneration Market, 2024
• Table 54 : Tissue Engineering and Regeneration: Recent Strategic Developments, 2022-2025
• Table 55 : ESG Rankings in Tissue Engineering and Regeneration Companies, 2025*
• Table 56 : ESG: Environmental Overview
• Table 57 : ESG: Social Overview
• Table 58 : ESG: Governance Overview
• Table 59 : Report Information Sources
• Table 60 : Abbreviations Used in the Global Tissue Engineering and Regeneration Market Report
• Table 61 : AbbVie Inc.: Company Snapshot
• Table 62 : AbbVie Inc.: Financial Performance, FY 2023 and 2024
• Table 63 : AbbVie Inc.: Product Portfolio
• Table 64 : AbbVie Inc.: News/Key Developments, 2023
• Table 65 : Alicorn Medical Pvt. Ltd.: Company Snapshot
• Table 66 : Alicorn Medical Pvt. Ltd.: Product Portfolio
• Table 67 : Alicorn Medical Pvt. Ltd.: News/Key Developments, 2025
• Table 68 : Baxter: Company Snapshot
• Table 69 : Baxter: Financial Performance, FY 2023 and 2024
• Table 70 : Baxter: Product Portfolio
• Table 71 : B. Braun SE: Company Snapshot
• Table 72 : B. Braun SE: Financial Performance, FY 2023 and 2024
• Table 73 : B. Braun SE: Product Portfolio
• Table 74 : BD: Company Snapshot
• Table 75 : BD: Financial Performance, FY 2023 and 2024
• Table 76 : BD: Product Portfolio
• Table 77 : BD: News/Key Developments, 2025
• Table 78 : BioTissue: Company Snapshot
• Table 79 : BioTissue: Product Portfolio
• Table 80 : BioTissue: News/Key Developments, 2022 and 2024
• Table 81 : Integra LifeSciences: Company Snapshot
• Table 82 : Integra LifeSciences: Financial Performance, FY 2023 and 2024
• Table 83 : Integra LifeSciences: Product Portfolio
• Table 84 : Integra LifeSciences: News/Key Developments, 2022
• Table 85 : Johnson & Johnson Services Inc.: Company Snapshot
• Table 86 : Johnson & Johnson Services Inc.: Financial Performance, FY 2023 and 2024
• Table 87 : Johnson & Johnson Services Inc.: Product Portfolio
• Table 88 : Medtronic: Company Snapshot
• Table 89 : Medtronic: Financial Performance, FY 2023 and 2024
• Table 90 : Medtronic: Product Portfolio
• Table 91 : MIMEDX Group Inc.: Company Snapshot
• Table 92 : MIMEDX Group Inc.: Financial Performance, FY 2023 and 2024
• Table 93 : MIMEDX Group Inc.: Product Portfolio
• Table 94 : MIMEDX Group Inc.: News/Key Developments, 2022-2024
• Table 95 : Organogenesis Inc.: Company Snapshot
• Table 96 : Organogenesis Inc.: Financial Performance, FY 2023 and 2024
• Table 97 : Organogenesis Inc.: Product Portfolio
• Table 98 : Smith+Nephew: Company Snapshot
• Table 99 : Smith+Nephew: Financial Performance, FY 2023 and 2024
• Table 100 : Smith+Nephew: Product Portfolio
• Table 101 : Smith+Nephew: News/Key Developments, 2023 and 2024
• Table 102 : Stryker: Company Snapshot
• Table 103 : Stryker: Financial Performance, FY 2023 and 2024
• Table 104 : Stryker: Product Portfolio
• Table 105 : Tecnoss: Company Snapshot
• Table 106 : Tecnoss: Product Portfolio
• Table 107 : Zimmer Biomet: Company Snapshot
• Table 108 : Zimmer Biomet: Financial Performance, FY 2023 and 2024
• Table 109 : Zimmer Biomet: Product Portfolio
• Table 110 : List of a Few Emerging Start-ups/ Market Disruptors

List of Figures

• Summary Figure : Global Market Shares of Tissue Engineering and Regeneration, by Region, 2024
• Figure 1 : Tissue Engineering: Triad
• Figure 2 : Porter's Five Forces Analysis of the Tissue Engineering and Regeneration Market
• Figure 3 : Market Dynamics of Tissue Engineering and Regeneration
• Figure 4 : Number of Publications, by Year, 2021-2024
• Figure 5 : AI in Tissue Engineering
• Figure 6 : AI: Global Leaders, Ranking, 2025
• Figure 7 : Impact of AI on Key Industry Verticals
• Figure 8 : Impact of AI on Value Chain
• Figure 9 : Emerging Trends/Technologies in the Tissue Engineering and Regeneration Market
• Figure 10 : Patents Granted, by Year, 2021-2024
• Figure 11 : Global Market Shares of Tissue Engineering and Regeneration, by Product Type, 2024
• Figure 12 : Global Market Shares of Scaffolds in Tissue Engineering and Regeneration, by Type, 2024
• Figure 13 : Global Market Shares of Grafts in Tissue Engineering and Regeneration, by Source, 2024
• Figure 14 : Global Market Shares of Tissue Engineering and Regeneration, by Material, 2024
• Figure 15 : Global Market Shares of Tissue Engineering and Regeneration, by Application, 2024
• Figure 16 : Global Market Shares of Tissue Engineering and Regeneration, by Region, 2024
• Figure 17 : North American Market Shares of Tissue Engineering and Regeneration, by Country, 2024
• Figure 18 : European Market Shares of Tissue Engineering and Regeneration, by Country, 2024
• Figure 19 : Asia-Pacific Market Shares of Tissue Engineering and Regeneration, by Country, 2024
• Figure 20 : Company Share Analysis of Tissue Engineering and Regeneration Market, 2024
• Figure 21 : ESG Pillars
• Figure 22 : Advantages of ESG for Companies
• Figure 23 : AbbVie Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 24 : AbbVie Inc.: Revenue Shares, by Country/Region, FY 2024
• Figure 25 : Baxter: Revenue Shares, by Business Unit, FY 2024
• Figure 26 : Baxter: Revenue Shares, by Country/Region, FY 2024
• Figure 27 : B. Braun SE: Revenue Shares, by Business Unit, FY 2024
• Figure 28 : B. Braun SE: Revenue Shares, by Country/Region, FY 2024
• Figure 29 : BD: Revenue Shares, by Business Unit, FY 2024
• Figure 30 : BD: Revenue Shares, by Country/Region, FY 2024
• Figure 31 : Integra LifeSciences: Revenue Shares, by Business Segment, FY 2024
• Figure 32 : Integra LifeSciences: Revenue Shares, by Country/Region, FY 2024
• Figure 33 : Johnson & Johnson Services Inc.: Revenue Shares, by Business Segment, FY 2024
• Figure 34 : Johnson & Johnson Services Inc.: Revenue Shares, by Country/Region, FY 2024
• Figure 35 : Medtronic: Revenue Shares, by Business Segment, FY 2024
• Figure 36 : Medtronic: Revenue Shares, by Country/Region, FY 2024
• Figure 37 : MIMEDX Group Inc.: Revenue Shares, by Business Segment, FY 2024
• Figure 38 : Organogenesis Inc.: Revenue Shares, by Business Segment, FY 2024
• Figure 39 : Smith+Nephew: Revenue Shares, by Business Segment, FY 2024
• Figure 40 : Smith+Nephew: Revenue Shares, by Country/Region, FY 2024
• Figure 41 : Stryker: Revenue Shares, by Business Segment, FY 2024
• Figure 42 : Stryker: Revenue Shares, by Country/Region, FY 2024
• Figure 43 : Zimmer Biomet: Revenue Shares, by Business Segment, FY 2024
• Figure 44 : Zimmer Biomet: Revenue Shares, by Country/Region, FY 2024

The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.

The North American market for tissue engineering and regeneration was valued at $2.1 billion in 2024 and is estimated to increase from $2.4 billion in 2025 to reach $4.5 billion by 2030, at a CAGR of 13.3% from 2025 through 2030.

The Asia-Pacific market for tissue engineering and regeneration was valued at $888.4 million in 2024 and is estimated to increase from $1 billion in 2025 to reach $2.1 billion by 2030, at a CAGR of 15.5% from 2025 through 2030.

Report Scope

The report provides an overview of the global tissue engineering and regeneration market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025, and projected data for 2026 through 2030.

The market is segmented into product type, material, and application. By product, the market is categorized into scaffolds and tissue grafts. By material, the market is segmented into biologically derived materials and synthetic materials. Based on application, the market is segmented into orthopedic and musculoskeletal disorders, dermatology and wound care, dental disorders, cardiovascular diseases, and others. Geographical regions covered in this study are North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), the Middle East and Africa (MEA), and South America, focusing on all the major countries in these regions.

The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses emerging technologies related to the market.

The report concludes by analyzing the competitive landscape and providing the ranking/share of key global tissue engineering and regeneration companies. It also contains a dedicated section of company profiles that covers details such as overview, key financials, product portfolio and recent developments in major companies.

Report Includes

• 47 data tables and 64 additional tables
• Analyses of the trends in global markets for tissue engineering and regeneration technologies, with historic revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
• Estimates of the market's size and revenue prospects, accompanied by a market share analysis by product type, material, application and region
• Facts and figures pertaining to market dynamics, technological advances, regulations and the impact of macroeconomic factors
• Insights derived from Porter's Five Forces model, as well as global supply chain analysis
• Patent analysis, featuring key granted and published patents
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Company profiles of major players within the industry, including Organogenesis Inc., Integra LifeSciences, Smith+Nephew, MiMedx Group Inc., and Johnson & Johnson Services Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Porter's Five Forces Analysis in the Tissue Engineering and Regeneration Market
• Potential for New Entrants (Moderate to High)
• Bargaining Power of Suppliers (Moderate to High)
• Bargaining Power of Buyers (High)
• Threat of Substitutes (Low to Moderate)
• Competition in the Industry (High)
• Macroeconomic Factor Analysis
• Aging Population
• Regulatory Environment
• Government Policy and Collaboration
• The U.S. Tariff Scenario

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Demand for Regenerative Medicine
• Growing Research and Approvals in Tissue Engineering
• Increasing Venture Capital Funding
• Market Restraints
• High Cost Associated with Treatment
• Complex Regulatory Pathway
• Market Opportunities
• Technological Advances
• Emerging Economies

Chapter 4 Regulatory Landscape

• The U.S.
• Europe
• Asia-Pacific

Chapter 5 Impact of AI Adoption on the Tissue Engineering and Regeneration Market

• Overview
• Case Studies
• Problem
• Solution
• Outcome
• AI Adoption: Trends
• Adoption Trends in North America
• Adoption Trends in Europe
• Adoption Trends in the Rest of the World
• AI Disruption Trends
• Impact of AI on Various Stages of the Value Chain
• Market Spending and Investment Scenario
• VC Investment in AI

Chapter 6 Emerging Technologies and Developments

• Emerging Technologies
• 3D Bioprinting
• Organ-on-a-Chip
• Smart Biomaterial
• Artificial Intelligence
• Clinical Trials Analysis
• Key Takeaways
• Clinical Trials Analysis, by Type of Study
• Clinical Trials Analysis, by Status
• Clinical Trials Analysis, by Phase
• Patent Analysis
• Key Takeaways
• Patents, by Year
• Patents by Top Applicant
• Patents by Top Owner
• Patents by Jurisdiction

Chapter 7 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Product Type
• Key Takeaways
• Scaffolds
• Biological Scaffolds
• Synthetic Scaffolds
• Grafts
• Allogenic
• Autogenic
• Synthetic
• Xenogeneic
• Market Analysis by Material
• Key Takeaways
• Biologically Derived Material
• Synthetic Material
• Market Analysis by Application
• Key Takeaways
• Orthopedics and Musculoskeletal Disorders
• Dermatology and Wound Care
• Dental Disorders
• Cardiovascular Diseases
• Others
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Middle East and Africa (MEA)
• South America

Chapter 8 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• Global Market Shares of Leading Companies
• Key Developments and Strategies

Chapter 9 Sustainability in Tissue Engineering and Regeneration: An ESG Perspective

• Introduction to ESG
• Sustainability in Tissue Engineering and Regeneration: An ESG Perspective
• Key ESG Issues
• Tissue Engineering and Regeneration ESG Performance Analysis
• Concluding Remarks from BCC

Chapter 10 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ABBVIE INC.
• ALICORN MEDICAL PVT. LTD.
• BAXTER
• B. BRAUN SE
• BD
• BIOTISSUE
• INTEGRA LIFESCIENCES
• JOHNSON & JOHNSON SERVICES INC.
• MEDTRONIC
• MIMEDX GROUP INC.
• ORGANOGENESIS INC.
• SMITH+NEPHEW
• STRYKER
• TECNOSS
• ZIMMER BIOMET
• A Few Emerging Start-ups/Market Disruptors